Page last updated: 2024-09-05

sb 203580 and Bladder Cancer

sb 203580 has been researched along with Bladder Cancer in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (55.56)29.6817
2010's4 (44.44)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiang, CH; Chung, JG; Hsu, FT1
Chiu, CC; Hour, TC; Hsu, SH; Hsu, WC; Hu, HT; Huang, AM; Kao, YT; Lin, CS; Lu, CY; Pu, YS1
Duan, F; Guan, R; Hong, L; Liang, H; Xu, Z; Yu, Y1
Deng, J; Feng, X; Geng, L; Jiang, G; Liu, J; Qian, Y; Wang, Y; Xie, H; Ye, Z; Yin, S; Zheng, S; Zhou, L1
Kim, WJ; Lee, SJ; Lee, US; Moon, SK; Park, SS1
Khandrika, L; Koul, HK; Koul, S; Kumar, B; Sinclair, J; Wilson, S1
Hwa, JS; Khandrika, L; Koul, HK; Koul, S; Kumar, B; Meacham, RB; Petersen, J; Wilson, S1
Ben-Ze'ev, A; Kosakowski, M; Lee, P; Libertino, JA; Moinzadeh, A; Rieger-Christ, KM; Stoffel, J; Summerhayes, IC; Zagha, R1
Cho, YH; Jung, KH; Kim, EJ; Kim, SK; Kim, WJ; Lee, SJ; Moon, SK; Park, K; Park, SS1

Other Studies

9 other study(ies) available for sb 203580 and Bladder Cancer

ArticleYear
Regorefenib induces extrinsic/intrinsic apoptosis and inhibits MAPK/NF-κB-modulated tumor progression in bladder cancer in vitro and in vivo.
    Environmental toxicology, 2019, Volume: 34, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Disease Progression; Humans; Imidazoles; MAP Kinase Signaling System; Mice; Mitogen-Activated Protein Kinases; Neoplasm Transplantation; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phenylurea Compounds; Pyridines; Signal Transduction; Urinary Bladder Neoplasms

2019
Involvement of p38 mitogen-activated protein kinase in acquired gemcitabine-resistant human urothelial carcinoma sublines.
    The Kaohsiung journal of medical sciences, 2014, Volume: 30, Issue:7

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Transitional Cell; Cell Line, Tumor; Cell Survival; Deoxycytidine; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Flavonoids; Gemcitabine; Humans; Imidazoles; p38 Mitogen-Activated Protein Kinases; Pyridines; Urinary Bladder Neoplasms

2014
Vitamin K2 Induces Mitochondria-Related Apoptosis in Human Bladder Cancer Cells via ROS and JNK/p38 MAPK Signal Pathways.
    PloS one, 2016, Volume: 11, Issue:8

    Topics: Anthracenes; Apoptosis; Cell Line, Tumor; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Membrane Potential, Mitochondrial; Mitochondria; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Reactive Oxygen Species; Urinary Bladder Neoplasms; Vitamin K 2

2016
TLR4 signaling induces B7-H1 expression through MAPK pathways in bladder cancer cells.
    Cancer investigation, 2008, Volume: 26, Issue:8

    Topics: Anthracenes; Antigens, CD; B7-H1 Antigen; Carcinoma, Transitional Cell; Cell Line, Tumor; Chromones; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharide Receptors; Lipopolysaccharides; MAP Kinase Signaling System; Morpholines; Neoplasm Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Pyridines; Toll-Like Receptor 4; Up-Regulation; Urinary Bladder Neoplasms

2008
Signaling pathway for TNF-alpha-induced MMP-9 expression: mediation through p38 MAP kinase, and inhibition by anti-cancer molecule magnolol in human urinary bladder cancer 5637 cells.
    International immunopharmacology, 2008, Dec-20, Volume: 8, Issue:13-14

    Topics: Antineoplastic Agents; Biphenyl Compounds; Cell Line, Tumor; Cell Movement; Enzyme Inhibitors; Humans; Imidazoles; Lignans; Matrix Metalloproteinase Inhibitors; NF-kappaB-Inducing Kinase; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; Signal Transduction; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

2008
Differential effects of MAPKs signaling on the growth of invasive bladder cancer cells.
    International journal of oncology, 2009, Volume: 34, Issue:6

    Topics: Apoptosis; Blotting, Western; Carcinoma, Transitional Cell; Cell Cycle; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Flavonoids; Humans; Imidazoles; Immunoenzyme Techniques; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Pyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2009
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.
    Cancer research, 2010, Jan-15, Volume: 70, Issue:2

    Topics: Cell Growth Processes; Cell Line, Tumor; Cell Movement; Humans; Imidazoles; Intracellular Signaling Peptides and Proteins; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyridines; RNA, Messenger; Transfection; Urinary Bladder Neoplasms

2010
Novel expression of N-cadherin elicits in vitro bladder cell invasion via the Akt signaling pathway.
    Oncogene, 2004, Jun-10, Volume: 23, Issue:27

    Topics: Blotting, Western; Cadherins; Carcinoma; Cell Line, Tumor; Chromones; Clone Cells; Collagen; Drug Combinations; Enzyme Activation; Enzyme Inhibitors; Flavonoids; Humans; Imidazoles; Immunohistochemistry; Laminin; Morpholines; Neoplasm Invasiveness; Phosphatidylinositol 3-Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Proteoglycans; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Pyridines; Serine; Signal Transduction; Transfection; Urinary Bladder Neoplasms

2004
Activation of matrix metalloproteinase-9 by TNF-alpha in human urinary bladder cancer HT1376 cells: the role of MAP kinase signaling pathways.
    Oncology reports, 2008, Volume: 19, Issue:4

    Topics: Butadienes; Cell Line, Tumor; DNA; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Matrix Metalloproteinase 9; Nitriles; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Pyridines; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

2008